Dr. Prashant Regmi | Clinical Biochemistry | Best Researcher Award

Lecturer at Clinical Biochemistry, Charles Darwin University, Australia

👨‍🎓He remarkable academic journey, extensive research contributions, and dedication to the field of psychology are truly commendable. Your wealth of knowledge and diverse skill set reflect a deep commitment to understanding and addressing critical issues such as bullying, inclusion, and socialization.

🔬 He successful completion of a PhD in Psychology, along with the numerous advanced courses and workshops, showcases your continuous pursuit of excellence and expertise in your field.

🏆 The awards and recognitions, including the First Place in the Poster Award at the University of Stavanger, underscore the impact of your research and the high regard it holds in the academic community.

Professional Profiles:

Education:

PhD in Medicine from The University of Adelaide, Australia (2017-2021) with a research focus on the Impact of Time-restricted feeding on glucose metabolism and metabolic health. M.Sc. in Clinical Biochemistry from the Institute of Medicine, Tribhuvan University, Nepal (2009-2012) with a Gold Medal. B.Sc. in Medical Laboratory Technology from BP Koirala Institute of Health Sciences, Nepal (2005-2008).

Experience:

Since March 2023: Lecturer-Biomedical Science at the Faculty of Health, Charles Darwin University, Australia. Responsibilities include teaching medical biochemistry, clinical biochemistry, and diagnostic haematology at both the bachelor’s and master’s levels, as well as conducting research projects and supervising research students. From October 2021 to March 2023: Clinical Trial Associate at Avance Clinical Research, Adelaide, Australia. Responsibilities included coordinating and managing clinical trials in Australia and New Zealand. From July 2013 to March 2017: Lecturer and Clinical Biochemist at Nepal Medical College and Teaching Hospital, Kathmandu, Nepal. Responsibilities included… (please provide the specific responsibilities for this position).

Prashant Regmi ‘s citation metrics and indices from Google Scholar are as follows:

Cited by: All: 859, Since 2018: 682
Citations: 859 (All), 682 (Since 2018)
h-index: 9 (All), 8 (Since 2018)
i10-index: 9 (All), 7 (Since 2018)

These metrics showcase the impact of Regmi ‘s work within the academic community, demonstrating the number of citations his publications have received and the influence of his research output.

Skills:

Dr. Prashant Regmi is highly proficient in various aspects of biochemistry, including real-time PCR, clinical chemistry, Western blotting, problem-based and case-based learning, metabolism, immunohistochemistry, pathophysiology, ELISA, cell and molecular biology, immunofluorescence, blood banking, endocrinology, flurometry/spectrophotometry, quality control of laboratory procedures, diagnostic biomarker interpretation, laboratory techniques, metabolic disease research, project management, clinical trials, curriculum design, as well as supervision/mentorship, student evaluation, education pedagogy, and scientific & succinct writing.

Award and Honors:

Nepal Vidhyabhusan ‘KHA’ (Nepal Education Medal ‘B’) from President Dr. Ram Baran Yadav of Nepal.
Society of Endocrinology Journal Award 2022, Harrogate, UK.
Top 12 highest scoring research, the Obesity week 2019, Las Vegas, USA.
Australian Permanent Residency as a Global Talent in Medical Science (Australian Government).

Memberships:

Dr. Prashant Regmi is a professional member (MAIMS) of the Australian Institute of Medical Scientists and a founder member of the Nepalese Association for Clinical Chemistry. They are also a professional member of the Nepal Health Professional Council (NHPC), specializing in Medical Biochemistry (registration No: 71) since October 29, 2015, and Diagnostic Health Laboratory (registration No: A-361) since May 10, 2009. Dr. Prashant Regmi served as the Treasurer of the Nepalese Association for Clinical Chemistry from January 2015 to February 2017 and has been a lifetime member of the Nepal Association for Medical Laboratory Science (NAMLS) since July 2009.

Publications:

Time‐Restricted Feeding Improves Glucose Tolerance in Men at Risk for Type 2 Diabetes: A Randomized Crossover Trial

Published in Energy in 2019 with 339 citations.

Association between glycaemic control and serum lipid profile in type 2 diabetic patients: Glycated haemoglobin as a dual biomarker.

Published in Energy in 2011 with 235 citations.

Time-restricted eating: benefits, mechanisms, and challenges in translation

Published in Energy in 2020 with 106 citations.

Pattern of dyslipidemia in type-2 diabetic subjects in Eastern Nepal

Published in Energy in 2009 with 40 citations.

Early or delayed time-restricted feeding prevents metabolic impact of obesity in mice

Published in Energy in 2021 with 33 citations.

Non-high density lipoprotein cholesterol versus low density lipoprotein cholesterol as a discriminating factor for myocardial infarction

Published in Energy in 2012 with 24 citations.

Hepatic involvement with elevated liver enzymes in Nepalese subjects with type 2 diabetes mellitus

Published in Energy in 2017 with 17 citations.

Product of serum calcium and phosphorus (Ca× PO4) as predictor of cardiovascular disease risk in predialysis patients